Advertisement

Author: Staff

Cambridge, Mass.-based InVivo Therapeutics enrolled a new patient in its INSPIRE Study, testing the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.

Advertisement
Advertisement